Specification

Page 3/8
Safety data sheet
according to 1907/2006/EC, Article 31
Printing date 18.03.2019 Revision: 18.03.2019Rev. 1
Trade name: LITOELASTIC EVO (FR) (comp A)
(Contd. of page 2)
48.1.27
Do not allow to enter sewers/ surface or ground water.
·
6.3 Methods and material for containment and cleaning up:
Absorb with liquid-binding material (sand, diatomite, acid binders, universal binders, sawdust).
Dispose contaminated material as waste according to item 13.
Ensure adequate ventilation.
·
6.4 Reference to other sections
See Section 7 for information on safe handling.
See Section 8 for information on personal protection equipment.
See Section 13 for disposal information.
SECTION 7: Handling and storage
·
7.1 Precautions for safe handling
Keep receptacles tightly sealed.
Ensure good ventilation/exhaustion at the workplace.
Prevent formation of aerosols.
·
Information about fire - and explosion protection:
No special measures required.
·
7.2 Conditions for safe storage, including any incompatibilities
·
Storage:
·
Requirements to be met by storerooms and receptacles:
No special requirements.
·
Information about storage in one common storage facility:
Not required.
·
Further information about storage conditions:
Store in a cool place.
Store in dry conditions.
Keep container tightly sealed.
·
7.3 Specific end use(s)
No further relevant information available.
SECTION 8: Exposure controls/personal protection
·
Additional information about design of technical facilities:
No further data; see item 7.
·
8.1 Control parameters
·
Ingredients with limit values that require monitoring at the workplace:
The product does not contain any relevant quantities of materials with critical values that have to be monitored at the
workplace.
·
Regulatory information
WEL (Great Britain): EH40/2018
·
DNELs
CAS: 25068-38-6 Reaction product: bisphenol-A-(epichlorhydrin) epoxy resin (number average molecular
weight

700)
Oral DNEL / Long term exposure - Systemic effects 0.75 mg/Kg bw/d (general population)
DNEL / Short term exposure - Systemic effects 0.75 mg/Kg (general population)
Dermal DNEL / Long term exposure - Systemic effects 3.6 mg/Kg bw/d (general population)
8.33 mg/Kg bw/d (workers)
DNEL / Short term exposure - Systemic effects 3.6 mg/Kg (general population)
8.33 mg/Kg (workers)
Inhalative DNEL / Long term exposure - Systemic effects 12.25 mg/m³ (workers)
DNEL / Short term exposure - Systemic effects 12.25 mg/m³ (workers)
CAS: 68609-97-2 Oxirane, mono[(C12-14-alkyloxy)methyl] derivs
Dermal DNEL / Long term exposure - Systemic effects 2.35 mg/Kg bw/d (general population)
3.9 mg/Kg bw/d (workers)
DNEL / Long term exposure - Local effects 1 mg/Kg (general population)
1.7 mg/Kg (workers)
DNEL / Short term exposure - Systemic effects 10 mg/Kg (general population)
17 mg/Kg (workers)
DNEL / Short term exposure - Local effects 40 mg/Kg (general population)
68 mg/Kg (workers)
Inhalative DNEL / Long term exposure - Systemic effects 4.1 mg/m³ (general population)
13.8 mg/m³ (workers)
DNEL / Long term exposure - Local effects 1.46 mg/m³ (general population)
(Contd. on page 4)
GB